The drug, discovered by Japan Tobacco and once in the hands of Merck, was licensed by BridgeBio in 2019.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback